Monograph Details
|
|
Central Nervous System
> Insomnia
|
|
DORAL |
| Manufacturer |
|
Questcor Pharmaceuticals |
| Legal Classification |
|
CIV |
| Pharmacological Class |
|
Benzodiazepine. |
| Generic Name |
|
Quazepam 15mg; tabs. |
| Indications |
|
Insomnia. |
| Children |
|
<18yrs: not recommended. |
| Adults |
|
≥18yrs: 15mg at bedtime. May reduce to 7.5mg at bedtime after 1–2 days. |
| Elderly |
|
Initially 7.5mg at bedtime; may increase to 15mg after 1–2 days. |
| Contraindications |
|
Sleep apnea. Pregnancy (Cat.X). |
| Precautions |
|
Drug or alcohol abuse. Avoid prolonged use. Withdraw gradually. Suicidal tendencies. Depression. Pulmonary, renal, or hepatic disease. Elderly. Debilitated. Nursing mothers: not recommended. |
| Interactions |
|
Potentiates CNS depression with alcohol, other CNS depressants. |
| Adverse Reactions |
|
CNS depression, complex sleep-related behaviors (eg, sleep-driving), ataxia, headache, dry mouth, GI upset, paradoxical excitement; anaphylaxis, angioedema. |
| How Supplied |
|
Tabs—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
